Heather Wakelee, MD (she/her/hers) – Stanford University ### 1047211###Presenter###Professor of Medicine and Chief of Oncology###Stanford University###
Presenter: Heather Wakelee, MD (she/her/hers) – Stanford University
### she/her/hers
9:45 AM – 10:45 AM ET
A Treatment Option for Patients With Resectable NSCLC Dual Immunotherapy + Platinum-Based Chemotherapy for the Treatment of mNSCLC
9:45 AM – 10:45 AM ET
Non-CME Innovation Theater (Sponsored by AstraZeneca)
Edward B. Garon, MD, MS – University of California, Los Angeles ### 758743###Presenter###Professor###University of California, Los Angeles###
Presenter: Edward B. Garon, MD, MS – University of California, Los Angeles
### @@@ Helen J. Ross, MD (she/her/hers) – Rush University ### 758420###Presenter###Thoracic Medical Oncologist, Director of Research and Clinical Trials###Rush University###
Presenter: Helen J. Ross, MD (she/her/hers) – Rush University
### she/her/hers @@@ Corey J. Langer, MD, FACP (he/him/his) – Abramson Cancer Center, Hospital of the University of Pennsylvania ### 758413###Presenter###Director of Thoracic Oncology###Abramson Cancer Center, Hospital of the University of Pennsylvania###
Presenter: Corey J. Langer, MD, FACP (he/him/his) – Abramson Cancer Center, Hospital of the University of Pennsylvania
### he/him/his @@@ Barbara Melosky, MD – Bc Cancer ### 1961092###Presenter###Medical Oncologist###Bc Cancer###
